Your browser doesn't support javascript.
loading
Opportunities for pharmacists to integrate pharmacogenomics into clinical practice.
Wang, Yan-Ting; Merl, Man Yee; Yang, Jun; Zhu, Zhi-Xiang; Li, Guo-Hui.
Afiliação
  • Wang YT; Department of Pharmacy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
  • Merl MY; Department of Pharmacy, Yale New Haven Hospital, New Haven, CT, 06510, USA. manyee.merl@ynhh.org.
  • Yang J; Department of Pharmacy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
  • Zhu ZX; Department of Pharmacy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
  • Li GH; Department of Pharmacy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China. lgh0603@126.com.
Pharmacogenomics J ; 20(2): 169-178, 2020 04.
Article em En | MEDLINE | ID: mdl-31796890
Many medical centers in the United States have implemented pharmacogenomics (PGx) programs to integrate PGx into clinical practice. The roles of pharmacists in optimizing medication use based on genetic testing results are emergently evolving. A literature search was conducted to assess pharmacists' roles in pharmacogenetics/pharmacogenomics or precision/personalized medicine programs. Fifteen PGx pharmacy practice models implemented in eleven hospitals and one community pharmacy in the U.S. were selected for evaluation. Pharmacists perform results interpretation, genotype-guided medication selection and adjustment, medication acquisition, adverse reactions monitoring, and patient education. Institutions that are interested in implementing a PGx program should plan the strategies to overcome the challenges, such as educational knowledge gaps, informatics, and reimbursement issues. Strong institutional support, well-defined goals, standardized procedures, and strategies to educate clinicians and patients are the prerequisites to comprehensively deliver genomic data for individualized drug therapy.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Farmacêuticos / Farmacogenética / Serviços Comunitários de Farmácia / Conduta do Tratamento Medicamentoso / Medicina de Precisão País/Região como assunto: America do norte Idioma: En Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Farmacêuticos / Farmacogenética / Serviços Comunitários de Farmácia / Conduta do Tratamento Medicamentoso / Medicina de Precisão País/Região como assunto: America do norte Idioma: En Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China